Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes

Xenobiotica

Volumn 38, Issue 6, 2008, Pages 574-586

  Price, R J ^a,b   Scott, M P ^a,b   Giddings, A M ^a,b   Walters, D G ^a,b   Stierum, R H ^c   Meredith, C ^d   Lake, B G ^a,b  

^a LFI Molecular Sciences   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c TNO   (Netherlands)

^d BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Butylated hydroxytoluene; Curcumin; CYP induction; Cytochrome P450 (CYP); Human hepatocytes; Propyl gallate; Thiabendazole

Indexed keywords

BUTYLCRESOL; CURCUMIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; ETHOXYRESORUFIN DEETHYLASE; GALLIC ACID PROPYL ESTER; MESSENGER RNA; TIABENDAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL; MALE;

AGED; ANTHELMINTICS; ANTIOXIDANTS; BUTYLATED HYDROXYTOLUENE; CELLS, CULTURED; CURCUMIN; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; PROPYL GALLATE; RNA, MESSENGER; STEROID HYDROXYLASES; THIABENDAZOLE;

EID: 45849110709     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250802008615     Document Type: Article

References (41)

1. Aix L, Rey-Grobellet X, Larrieu G, Lesca P, Galtier P. 1994. Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochemical and Biophysical Research Communications 202:1483-1489.
2. Backlund M, Weidulf L, Ingelman-Sundberg M. 1999. Structural and mechanistic aspects of transcriptional induction of cytochrome P450 1A1 by benzimidazole derivatives in rat hepatoma H4IIE cells. European Journal of Biochemistry 261:66-71.
3. Chang TKH, Yu L, Maurel P, Waxman DJ. 1997. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Research 57:1946-1954.
4. Coecke S, Rogiers V, Bayliss M, Castell J, Doehmer J, Fabre G, Fry J, Kern A, Westmoreland C. 1999. The use of long-term hepatocyte cultures for detecting induction of drug metabolising enzymes: The current status. ECVAM Hepatocytes and Metabolically Competent Systems Task Force Report 1. Alternatives to Laboratory Animals 27:579-638.
5. Depner M, Kahl GF, Kahl R. 1982. Influence of gallic acid esters on drug-metabolizing enzymes of rat liver. Food and Chemical Toxicology 20:507-511.
6. Dickins M. 2004. Induction of cytochromes P450. Current Topics in Medicinal Chemistry 4:1745-1766.
7. Gerbal-Chaloin S, Pascussi J-M, Pichard-Garcia L, Daujat M, Waechter F, Fabre J-M, Carrère N, Maurel P. 2001. Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metabolism and Disposition 29:242-251.
8. Gross-Steinmeyer K, Stapelton PL, Liu F, Tracy JH, Bammler TK, Quigley SD, Farin FM, Buhler DR, Safe SH, Strom SC, et al. 2004. Phytochemical-induced changes in gene expression of carcinogen-metabolizing enzymes in cultured human primary hepatocytes. Xenobiotica 34:619-632.
9. Groten JP, Butler WH, Feron VJ, Kozianowski G, Renwick AG, Walker R. 2000. An analysis of the possibility for health implications of joint actions and interactions between food additives. Regulatory Toxicology and Pharmacology 31:77-91.
10. Hewitt NJ, Gómez Lechon MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, et al. 2007. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metabolism Reviews 39:159-234.
11. Honkakoski P, Negishi M. 2000. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochemical Journal 347:321-337.
12. Kikuchi H, Kato H, Mizuno M, Hossain A, Ikawa S, Miyazaki J, Watanabe M. 1996. Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: Evidences of a human-specific signal transduction pathway for CYP1A1 induction. Archives of Biochemistry and Biophysics 334:235-240.
13. LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R, Parkinson A. 2000. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. Journal of Biochemical and Molecular Toxicology 14:177-188.
14. LeCluyse EL. 2001. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. European Journal of Pharmaceutical Sciences 13:343-368.
15. Lin JH. 2006. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharmaceutical Research 23:1089-1116.
16. Madan A, Graham RA, Carroll KM, Mudra DR, Burton LA, Krueger LA, Downey AD, Czerwinski M, Forster J, Ribadeneira MD, et al. 2003. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metabolism and Disposition 31:421-431.
17. 1 metabolism. Carcinogenisis 18:1729-1738.
18. Maurel P. 1996. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Advanced Drug Delivery Reviews 22:105-132.
19. McFarlane M, Price SC, Cottrell S, Grasso P, Bremmer JN, Bomhard EM, Hinton RH. 1997. Hepatic and associated response of rats to pregnancy, lactation and simultaneous treatment with butylated hydroxytoluene. Food and Chemical Toxicology 35:753-767.
20. Meredith C, Scott MP, Renwick AB, Price RJ, Lake BG. 2003. Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica 33:511-527.
21. Moore JT, Moore LB, Maglich JM, Kliewer SA. 2003. Functional and structural comparison of PXR and CAR. Biochimical et Biophysical Acta 1619:235-238.
22. Nims R, Lubet RA. 1996. The CYP2B subfamily. In: Ioannides C, editor. Cytochromes P450: Metabolic and toxicological aspects. Boca Raton, FL: CRC Press. pp 135-160.
23. Oetari S, Sudibyo M, Commandeur JN, Samhoedi R, Vermeulen NP. 1996. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochemical Pharmacology 51:39-45.
24. Okey AB. 1990. Enzyme induction in the cytochrome P-450 system. Pharmacology and Therapeutics 45:241-298.
25. Parkinson A. 2001. Biotransformation of xenobiotics. In: Klaassen CD, editor. Casarett and Doull's toxicology: The basic science of poisons. 6th ed. New York, NY: McGraw-Hill. pp 133-224.
26. Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. 2004. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicology and Applied Pharmacology 199:193-209.
27. Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, Raunio H. 1998. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203-1253.
28. Ponsoda X, Gómez-Lechón MJ, Castell JV. 1998. Toxicity and cell density monitoring in monolayer and threedimensional cultures with the XTT assay. Alternatives to Laboratory Animals 26:331-342.
29. Price RJ, Giddings AM, Scott MP, Walters DG, Capen C, Osimitz TG, Lake BG. 2008. Effect of pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. Toxicology 243:84-95.
30. Price RJ, Scott MP, Walters DG, Stierum RH, Groten JP, Meredith C, Lake BG. 2004. Effect of thiabendazole on some rat hepatic xenobiotic metabolising enzymes. Food and Chemical Toxicology 42:899-908.
31. Price RJ, Surry D, Renwick AB, Meneses-Lorente G, Lake BG, Evans DC. 2000. CYP isoform induction screening in 96-well plates: Use of 7-benzyloxy-4-trifluoromethylcoumarin as a substrate for studies with rat hepatocytes. Xenobiotica 30:781-795.
32. Raucy JL. 2003. Regulation of CYP3A4 expression in human hepactoytes by pharmaceuticals and natural products. Drug Metabolism and Disposition 31:533-539.
33. Rey-Grobellet X, Ferre N, Eeckhoutte C, Larrieu G, Pineau T, Galtier P. 1996. Structural requirements for the induction of cytochromes P450 by benzimidazole anthelmintic derivatives in cultured rabbit hepatocytes. Biochemical and Biophysical Research Communications 220:789-794.
34. Sharma RA, Gescher AJ, Steward WP. 2005. Curcumin: The story so far. European Journal of Cancer 41:1955-1968.
35. Stubberfield CR, Cohen GM. 1989. Interconversion of NAD(H) to NADP(H). A cellular response to quinone-induced oxidative stress in isolated hepatocytes. Biochemical Pharmacology 38:2631-2637.
36. Sun B, Fukuhara M. 1997. Effects of co-administration of butylated hydroxytoluene, butylated hydroxyanisole and flavonoids on the activities of mutagens and drug-metabolizing enzymes in mice. Toxicology 122:61-72.
37. Sun B, Fukuhara M, Kinoshita T, Kimura M, Ushio F. 1996. Differential induction of drug-metabolizing enzymes by butylated hydroxytoluene in mice and Chinese hamsters. Food and Chemical Toxicology 34:595-601.
38. Thapliyal R, Maru GB. 2001. Inhibition of cytochrome P450 isozymes by curcumin in vitro and in vivo. Food and Chemical Toxicology 39:541-547.
39. Walton K, Walker R, Van de Sandt JJM, Castell JV, Knapp AGAA, Kozianowski G, Roberfroid M, Schilter B. 1999. The application of in vitro data in the derivation of the acceptable daily intake of food additives. Food and Chemical Toxicology 37:1175-1197.
40. Wang H, Faucette SR, Gilbert D, Jolley S, Sueyoshi T, Negishi M, LeCluyse EL. 2003. Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metabolism and Disposition 31:620-630.
41. Zimmerman HJ. 1978. The adverse effects of drugs and other chemicals on the liver. New York, NY: Appleton-Century-Crofts. p 342.